TrimRx's Blog

9 min read

Mounjaro Weight Loss by Week: Full Timeline

Mounjaro is tirzepatide approved for type 2 diabetes, dosed once weekly. The same molecule is sold as Zepbound for weight management.

8 min read

Mounjaro Shortage: When Will It End

The Mounjaro shortage was declared resolved by the FDA in December 2024, alongside Zepbound, which shares the same tirzepatide molecule.

9 min read

Mounjaro Results After Month 6: Realistic Weight Loss Expectations

Six months on Mounjaro is where the dual GIP/GLP-1 mechanism really separates from pure GLP-1 therapies.

9 min read

Mounjaro Results After Month 3: Realistic Weight Loss Expectations

Three months on Mounjaro lands most patients at 9 to 12 percent body weight loss and 2 to 3 dose escalations into the protocol.

9 min read

Mounjaro Results After Month 2: Realistic Weight Loss Expectations

Month 2 on Mounjaro is when most patients stop questioning whether the medication is working.

9 min read

Mounjaro Results After 1 Year: Realistic Weight Loss Expectations

A year on Mounjaro is the data point that reshaped the GLP-1 landscape. SURMOUNT-1 (Jastreboff et al.

9 min read

Mounjaro Results After Month 1: Realistic Weight Loss Expectations

One month on Mounjaro is the first real signal that the medication is working.

8 min read

Mounjaro Rash: Skin Reactions Explained

Tirzepatide trials told us early that injection-site reactions would be more common with Mounjaro than with older GLP-1 drugs.

7 min read

Mounjaro Insomnia: Why It Happens and How to Manage

Mounjaro and Zepbound are the same drug, tirzepatide, with the same active ingredient and same dosing.

Stay on Track

Join our community and receive:
Expert tips on maximizing your GLP-1 treatment.
Exclusive discounts on your next order.
Updates on the latest weight-loss breakthroughs.